PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Sengenics

Press Release

Share      Blog

Receive press releases from Sengenics: By Email PDF Version RSS Feeds:

Parkway Laboratories and Sengenics Enter Into an Exclusive Partnership to Provide Pioneering Genetic Tests in Singapore


Biopolis, Singapore, April 25, 2013 --(PR.com)-- Sengenics, a leading genetic diagnostics company and Parkway Laboratory Services, the premier private laboratory services provider in Singapore, and part of the Parkway Pantai group, the largest private healthcare provider in the region, announced today that they have entered into an exclusive partnership to provide cutting-edge genetic tests in Singapore.

The partnership will focus on providing the Sengenics CardioSURE Heart disease genetic risk test and Sequenom's MaterniT21 PLUS non-invasive pre-natal diagnostic test that covers Trisomy 21, 18 and 13.

To date, most genetic tests are based on Caucasian genetic markers, whereas CardioSURE is based on the concept of "Asianised Diagnostics." This is essentially the incorporation of disease-specific markers from Asian ethnic groups as well as those from Caucasian and African populations.

Dr. Adzuan Abdul Rahman, Parkway Lab COO, said, "Parkway Lab has been on the lookout for the right partner to provide cutting-edge genetic testing for our patients. Given the technology capabilities and experience of Sengenics, we have selected them as our exclusive partner for these tests."

"A key part of our regional expansion is to partner with leading healthcare service providers in strategic locations who have a strong track record and reputation for excellence. Parkway Pantai is a strong fit for our long-term vision for the region. We are continuing our aggressive regional roll-out and plan to make further announcements relating to additional regional partners in the next few months," said Johan Poole-Johnson, Commercial Director of Sengenics.

The tests will be made progressively available through Parkway Lab from May 1, 2013.

About Parkway Laboratory Services Ltd.
At Parkway Lab, we provide quality services in the areas of clinical laboratory, histopathology and genetics. With an experienced laboratory team and well-equipped laboratories located within Gleneagles Hospital, Mount Elizabeth Orchard Hospital, Mount Elizabeth Novena Hospital and Parkway East Hospital, a satellite outpatient laboratory in Novena Medical Center and a reference laboratory in our headquarters at Ayer Rajah Crescent, we serve the needs of inpatients and outpatients at our four hospitals as well as medical practitioners who operate within and outside the hospitals’ medical centres.

About Sengenics
Sengenics was the 1st company outside the USA to offer genomics-based diagnostics services. The key focus areas for the company are Diagnostics and Research Services using next-generation sequencing, protein and DNA microarray technologies. The business model of the company also leverages the translation of joint research projects into patented and commercialized diagnostics tests. Sengenics has established a wide network of partners in the US, Europe and Asia as channels for its products and services. The company has sales offices and genetic testing facilities in four countries.

Parkway Contact
Parkway Laboratory Genetics
Email: enquiriesMat21@parkway.sg
Tel: +65 6248 5873 or +65 6248 5874

Sengenics Contact
Buzzlair Voufincci
enquiries@sengenics.com
www.sengenics.com
Contact Information
Sengenics
Buzzlair Voufincci
+60 (0)3 7960 2881
Contact
www.sengenics.com

Click here to view the list of recent Press Releases from Sengenics
Promote Your Business